In operation since 1968, the Albert Einstein College of Medicine Division of Substance Abuse (DoSA) is the second largest public treatment program in New York State, serving over 3500 Bronx residents in three neighborhood clinical facilities. The program's primary focus has been the treatment of opioid dependence through the methadone maintenance modality and Medically Supervised Drug Free Treatment.
Innovative services have been developed with special focus on the children and families of patients, on persons with cocaine addiction, and on patients at high risk for HIV and HCV-related illnesses. The Division is funded through the New York State Office of Alcoholism and Substance Abuse Services (OASAS) NYS AIDS Institute, is licensed and approved by OASAS, the New York State Department of Health, the U.S. Drug Enforcement Administration, and the U.S. Food and Drug Administration and is accredited by CARF.
The clinic population is approximately 60% males and 40% females: 40% white, 40% hispanic, and 20% black. The ages range from 19 to 70. The diagnoses, other than the predominant opioid dependencies, include the gamut of chemical dependencies, including a substantial minority using cocaine and alcohol; and a substantial number of the patients carry non-substance-related psychiatric diagnoses - including: major depressive disorder, bipolar disorder, schizophrenia, schizoaffective disorder, panic disorder, post-traumatic stress disorder, sleep disorders, sexual disorders, and personality disorders.
The types of treatment provided include methadone maintenance, buprenorphine treatment, methadone-to-abstinence detoxification, psychotropic medications (antidepressants, mood stabilizers, non-habit-forming sedatives), individual/group/family counseling, psychotherapy, 12-step groups, and primary care treatment including HIV and HCV.
Fellows are required to spend 5-10% of the fellowship year doing an independent clinical or basic science research or independent study project of their choice. Those with a greater interest in research may opt for a half time clinical half term research position that will extend over 2 years.
Trainees are encouraged to make a presentation of their research at a relevant meeting or to produce a scholarly paper on their research. All fellows will present a clinical or research lecture in the addiction psychiatry course and/or in a departmental Grand Rounds.
Trainees receive 2 hours of individual supervision weekly and clinical supervision at sites. This includes off site supervision by the Program Director, Merrill Herman, MD, which includes clinical case presentations, supervision on psychotherapy and pharmacotherapeutic modalities. On-Site supervision includes directly observed interviews with patients.